Skip to content
  • Wednesday, 28 October 2026
  • 2:20 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead and Nucleai probe why target-positive tumors can still resist ADCs
Laboratory Automation & Robotics

Gilead and Nucleai probe why target-positive tumors can still resist ADCs

Lana Keisha Sep 29, 2026 0

Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, evolving from a theoretical "magic bullet" concept into a…

Read More
Laboratory Automation & Robotics

FDA issues final PDUFA meeting guidance, expands use of written responses

Lana Keisha Sep 28, 2026 0

The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between the agency and…

Read More
Laboratory Automation & Robotics

AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.

Lana Keisha Sep 28, 2026 0

In the global effort to eradicate hepatitis C (HCV), clinical success has frequently collided with the sobering realities of public…

Read More
Laboratory Automation & Robotics

How Sheba Medical Center became OpenAI’s first international hospital partner

Lana Keisha Sep 28, 2026 0

The landscape of global healthcare is undergoing a seismic shift as Sheba Medical Center, Israel’s largest and most prominent healthcare…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Sep 27, 2026 0

The landscape of modern pharmacology shifted fundamentally in May 2026 with the U.S. Food and Drug Administration’s approval of vepdegestrant,…

Read More
Laboratory Automation & Robotics

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

Lana Keisha Sep 27, 2026 0

The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna move toward…

Read More
Laboratory Automation & Robotics

2026 PharmSci 360 adds tracks on research credibility and post-animal drug development

Lana Keisha Sep 27, 2026 0

The American Association of Pharmaceutical Scientists (AAPS) has announced a significant evolution for its flagship annual conference, PharmSci 360, which…

Read More
Laboratory Automation & Robotics

Cancer vaccine borrows COVID immune memory to activate T cells against tumors in mice

Lana Keisha Sep 27, 2026 0

The global landscape of immunology has been irrevocably altered by the COVID-19 pandemic, leaving behind a massive, worldwide cohort of…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 26, 2026 0

The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of synthetic alkaloids…

Read More
Laboratory Automation & Robotics

After decades of trial failures in chemotherapy-linked neuropathy, psilocybin shows promise in preventing it in mice

Lana Keisha Sep 26, 2026 0

For millions of cancer patients worldwide, the life-saving potential of chemotherapy is frequently tempered by a debilitating side effect known…

Read More

Posts pagination

1 … 6 7 8 … 53
Harvard Researchers Unveil the First Comprehensive Map of Smell Receptors and the Hidden Logic of OlfactionJAMA Study Uncovers Moderate Caffeine Intake’s Link to Reduced Dementia Risk, Highlighting Adenosine Pathway for Drug DevelopmentScience News: A Centennial of Empowering Public Understanding of ScienceRevolutionizing Neuroscience: Andreas Pfenning Unlocks Brain Heterogeneity for Targeted Therapies
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial CancerThe Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026
Molecular & Cell Biology
The Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
Angie Faith Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ